Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The Consort (Consolidated Standards Of Reporting Trials)
28
Zitationen
5
Autoren
2017
Jahr
Abstract
Background and Objective: Interventional clinical trial is the study in which the participants are simultaneously placed in the intervention and control groups to investigate the cause-effect relationship between an intervention and an outcome. Because of the probability of some bias in human intervention, non-standard clinical trials design produce unreal interventional results. For standardizing the clinical trials, Consolidated Standards of Reporting Trials (CONSORT) statement was presented that is a guideline including the design, implementation and reporting of the results. CONSORT statement includes a flowchart and a Flow Diagram. CONSORT statement has a 25-item list that describes how to write a title, abstract, introduction, methods, results, discussion, registration, and access study protocol and sources of research funding. In the Flow Diagram of CONSORT, the way to access the participants, along the study, is taken into consideration. Of the importance of clinical trials on new diagnostic and therapeutic methods, present study was conducted to survey and evaluate the performance of CONSORT statement. Key words: Clinical trial, Randomized Clinical Trial, Intervention, Consort Funding: This research was funded by Rafsanjan University of Medical Sciences. Conflict of interest: None declared. Ethical approval: The Ethics Committee of Rafsanjan University of Medical Sciences approved the study. How to cite this article: Ayoobi F, Rahmani MR, Assar S, Jalalpour S, Rezaeian M. The Consort (Consolidated Standards Of Reporting Trials). J Rafsanjan Univ Med Sci 2017; 15(10): 977-94. [Farsi]
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 39.048 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 38.923 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.749 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.901 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 29.603 Zit.